An update from Sirnaomics Ltd. ( (HK:2257) ) is now available.
Sirnaomics Ltd. has announced the composition of its Board of Directors, highlighting the roles and committee memberships of each member. This strategic structuring of the board aims to strengthen the company’s governance and leadership framework, potentially enhancing its operational efficiency and market positioning.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a biotechnology company specializing in the development of RNAi-based therapeutics for the treatment of diseases with unmet medical needs. The company operates within the pharmaceutical industry, focusing on innovative therapies targeting oncology and fibrosis indications.
YTD Price Performance: -9.54%
Average Trading Volume: 137,128
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$329.2M
For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.